Abstracts of oral presentations, Riechman et al, “Recombinant Antibodies,” University of London . . . Medical School (1997). |
Riechmann, L. et al. “Reshaping human antibodies for . . . ”Nature, vol. 332, Mar. 24, 1988, pp. 323-327. |
Jones, P.T. et al. “Replacing the complementarity . . . ” Nature, vol. 321, May 29, 1986, pp. 522-525. |
G. Hale et a. “Effects of monoclonal . . . ” Mol. Biol. Med. (1983) 1, pp. 321-334. |
S. Roberts et al. “Generation of an antibody . . . ”Nature, vol. 328, (1987), pp. 731-734. |
G. Hale et al. “Isolation of low-frequency . . . ” Jour. of Immunological Methods, 103(1987), pp. 59-67. |
Hale et al. “Removable of T cells from bone . . . ” Mol. Biol. Med., 1983, 1, pp. 305-319. |
Hale et al. “Removal of T cells from . . . ” Blood, 1983, 62, pp. 873-882. |
Hale et al. “Pilot study of . . . ”Transplantation, 1986, 42, pp. 308-311. |
Hale et al. “Remission induction . . . ” The Lancet, Dec. 17, 1988, pp. 1394-1399. |
Schumaker et al. “Ultracentrifuge . . . ” Biochemistry, 1976, 15, pp. 5175-5181. |
Liu et al. “Chimeric mouse-human . . . ”Proc. Natl Acad. of Sci. USA, 1987, 84, pp. 3439-3442. |
Shaw et al. “Characterization of a mouse/human . . . ” Jour of Immunol., 1987, 138m, pp. 4534-4538. |
Bruggemann et al. “Comparison of the effector . . . ” J. Exp. Med. 1987, 166, pp. 1351-1361. |
Bindon. “Human monoclonal IgG . . . ” J. Exp. Med. 1988, 168, pp. 127-142. |
Stepleswki et a. “Biological activity of human-. . . ” Proc. Natl. Acad. of Sci. USA, 1988, 85, pp. 4852-4856. |
Dangl et al. “Segmental flexibility . . . ” EMBO Journal, 1988, 7, pp. 1989-1994. |
M. Verhoeyen et al. “Reshaping human antibodies . . . ” Science, vol. 239, Mar. 25, 1988, pp. 1534-1536. |
G. Hale et a. “Therapeutic Potential of Rat Monoclonal Antibodies . . . ” The Journal of Immunology, vol. 134 No. 5 (May 1985), pp. 3056-3061. |